DeepMind spin-off Isomorphic Labs raises $5 billion to design drugs with AI; vision-implant maker Science Corp raises $400 million
Investors put more than $6.6 billion into nine startups on Wednesday, led by two big bets on AI and health.
- Isomorphic co-leads: Greenoaks, Sequoia
- Science Corp raised over $900 million since 2021
- $6.6 billion+ raised by 9 startups on 18 Nov
Isomorphic Labs
London-based Isomorphic Labs, spun out of Google DeepMind, raised $5 billion in a round co-led by Greenoaks and Sequoia Capital, with Andreessen Horowitz, Alphabet, Thrive Capital, GV, Temasek and the UK Sovereign AI Fund also investing. It did not share its valuation.
It builds an AI system that proposes and refines drug molecules before lab work, and partners with Eli Lilly, Novartis and Johnson & Johnson. This comes on top of a $2.1 billion round in May.
Science Corporation
Science Corp raised $400 million in a Series D, reportedly at a $3.5 billion valuation. Its PRIMA system, a retinal implant with special glasses, helps some people with late-stage retinal disease see shapes again. It is sold in Europe and is seeking US approval.





